Evidence map›Paper›PMID 37353970›Full record

Trial reportThe Australian and New Zealand journal of psychiatry2024

'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services.

Amanda L Baker, Kristen McCarter, Alyna Turner, Catherine Segan, David Castle, Lisa Brophy, Ron Borland, Peter J Kelly, Billie Bonevski, Donita Baird and 12 more

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The Australian and New Zealand journal of psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 3 countries.

Amanda L BakerSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.
Kristen McCarterSchool of Psychological Sciences, College of Engineering, Science and Environment, University of Newcastle, Callaghan, NSW, Australia.ORCID 0000-0002-2638-6381
Alyna TurnerSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.
Catherine SeganCancer Council Victoria, Melbourne, VIC, Australia.
David CastleCentre for Complex Interventions, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, ON, Canada.
Lisa BrophyMelbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Ron BorlandCancer Council Victoria, Melbourne, VIC, Australia.
Peter J KellyIllawarra Health and Medical Research Institute and the School of Psychology, University of Wollongong, Wollongong, NSW, Australia.
Billie BonevskiFlinders Health and Medical Research Institute (FHMRI), College of Medicine & Public Health, Flinders University, Bedford Park, SA, Australia.
Donita BairdSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.
Sacha FiliaCancer Council Victoria, Melbourne, VIC, Australia.
John AttiaSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.
Stuart SzwecHunter Medical Research Institute, Newcastle, NSW, Australia.
Kerrin PalazziHunter Medical Research Institute, Newcastle, NSW, Australia.
Sarah L WhiteCancer Council Victoria, Melbourne, VIC, Australia.
Jill M WilliamsDivision of Addiction Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Anna L WrobelIMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia.ORCID 0000-0002-1864-0394
Andrew IrelandCentre for Health Economics, Monash Business School, Monash University, Melbourne, VIC, Australia.
Karinna SaxbyCentre for Health Economics, Monash Business School, Monash University, Melbourne, VIC, Australia.
Peter GhijbenCentre for Health Economics, Monash Business School, Monash University, Melbourne, VIC, Australia.
Dennis PetrieCentre for Health Economics, Monash Business School, Monash University, Melbourne, VIC, Australia.
Rohan SweeneyCentre for Health Economics, Monash Business School, Monash University, Melbourne, VIC, Australia.
Monash University · AUUniversity of Newcastle Australia · AUThe University of Melbourne · AUCancer Council Victoria · AUHunter Medical Research Institute · AUBarwon Health · AUCentre for Addiction and Mental Health · CADeakin University · AUFlinders University · AURutgers, The State University of New Jersey · USUniversity of Wollongong · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to test the effectiveness of a tailored quitline tobacco treatment ('Quitlink') among people receiving support for mental health conditions.

methodsWe employed a prospective, cluster-randomised, open, blinded endpoint design to compare a control condition to our 'Quitlink' intervention. Both conditions received a brief intervention delivered by a peer researcher. Control participants received no further intervention. Quitlink participants were referred to a tailored 8-week quitline intervention delivered by dedicated Quitline counsellors plus combination nicotine replacement therapy. The primary outcome was self-reported 6 months continuous abstinence from end of treatment (8 months from baseline). Secondary outcomes included additional smoking outcomes, mental health symptoms, substance use and quality of life. A within-trial economic evaluation was conducted.

resultsIn total, 110 participants were recruited over 26 months and 91 had confirmed outcomes at 8 months post baseline. There was a difference in self-reported prolonged abstinence at 8-month follow-up between Quitlink (16%,

conclusionThe Quitlink intervention did not result in significantly higher rates of prolonged abstinence at 8 months post baseline. However, engagement rates and satisfaction with the 'Quitlink' intervention were high. While underpowered, the Quitlink intervention shows promise. A powered trial to determine its effectiveness for improving long-term cessation is warranted.

Indexed as

Mental Health ServicesSmoking CessationHumansProspective StudiesQuality of LifeReferral and ConsultationTobacco Use Cessation Devicescost analysismental ill-healthpeer workerquitlinesevere mental ill-healthsmoking cessationtelephone counsellingTobacco treatment

Identifiers

PMID37353970
PMCPMC10903138
OpenAlexW4381839137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.